PHILADELPHIA, PA -- (Marketwired) -- 07/08/13 -- Invisible Sentinel Inc., a life-sciences company that develops tools for the detection of foodborne pathogens, announced today it has been awarded a patent for its proprietary Veriflow diagnostic technology.
The United States Patent and Trademark Office has issued Invisible Sentinel U.S. Patent No. 8,476,082, entitled "Device For Detection of Target Molecules And Uses Thereof."
This is the third issued United States patent for Invisible Sentinel related to the Company's first-in-class test kits to enhance surveillance for foodborne pathogens.
"This patent is another significant milestone for the Company," said Nick Siciliano, Chief Executive Officer and co-founder of Invisible Sentinel. "It adds further value to our growing intellectual-property portfolio and comes as we accelerate sales and marketing of our Veriflow technology."
Veriflow technology represents a new class of molecular diagnostics that offer precision and ease of use to food producers, processors, distributors, and retailers as well as government health officials.
The first certification by the Association of Analytical Communities International (AOAC) for this novel class of diagnostics came last October, when the AOAC certified Veriflow Campylobacter (Veriflow CA) to detect Campylobacter jejuni and Campylobacter coli in poultry. Then in May 2013 the AOAC certified Veriflow Listeria monocytogenes (Veriflow LM) for the detection of L. monocytogenes from a variety of environmental and food matrices.
Currently in the AOAC review process for certification are additional Veriflow assays to detect pan-Listeria species and pan-Salmonella species. Veriflow assays for the detection of Shiga toxin-producing Escherichia coli (STEC) are also slated for AOAC submission this year.
Veriflow CA and LM are available directly from Invisible Sentinel. Orders can be placed by calling (215) 966-6118.
About Invisible Sentinel
Based in Philadelphia at the University City Science Center, Invisible Sentinel develops diagnostic technologies for a safer food supply. The Company's focus is on developing rapid diagnostics that quickly provide accurate information about the presence of harmful pathogens. The first-in-class patented technology, produced under good manufacturing practices, provides the same data as the US Department of Agriculture reference methods but minimizes the time, reduces the cost, and lowers the overhead associated with conventional diagnostics. The food industry is the first market that the Company is targeting, but its platform technology has the potential to provide valuable tools for additional industries including healthcare, veterinary, biodefense, and environmental testing, where rapid detection of target analytes from unrefined samples is critical. Uniquely designed for easy, practical use -- on-site and throughout the entire food distribution network -- Invisible Sentinel's proprietary diagnostic products promise to create a new standard for rigorous quality control.
About the University City Science Center
The University City Science Center accelerates technology commercialization, regional economic development, and the market availability of life-enhancing scientific breakthroughs by bringing together innovations, scientists, entrepreneurs, funding, laboratory facilities, and business services. Established in 1963 and headquartered in Philadelphia, PA, the Science Center was the first, and remains the largest, urban research park in the United States. Graduate organizations and current residents of the University City Science Center's Port business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. For more information about the Science Center, go to www.sciencecenter.org.
Invisible Sentinel Inc.
Most Popular Stories
- Bipartisan Budget Deal Gets Key Support in House
- TFA Recruiting DACA Recipients
- Bitcoin Clones Lurch Onto Financial Scene
- Clinton to Keynote Annual Simmons Leadership Conference
- Holiday Shopping Off to a Slow Start This Season
- Scotch Whisky Sales Raise Distillers' Spirits
- Podesta Likely to Reject Keystone XL
- Health Coverage Disparities Emerge Among States
- Fake Deaf Interpreter Was Hallucinating, Has Schizophrenia
- Tea Party Glum in Face of Bipartisan Budget Deal